ArticleCureus2025
Recurrent Subdural Hematoma Revealing Undiagnosed Mild Hemophilia A and Factor XIII Deficiency in an Elderly Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent acute subdural hematoma (ASDH) is uncommon and typically associated with trauma, vascular malformations, or coagulopathies. While hemophilia is usually diagnosed in childhood, mild forms may remain undetected until adulthood, potentially presenting with unexpected perioperative bleeding. We report the case of a 75-year-old male who sustained a traumatic head injury resulting in ASDH along the falx cerebri and left frontotemporal region. Initial conservative management was followed by neurological deterioration associated with worsening cerebral edema, requiring emergent craniotomy. Postoperative rebleeding occurred twice, necessitating a total of three craniotomies. A coagulation workup after the second reoperation revealed decreased factor VIII ([FVIII] 22%) and factor XIII ([FXIII] 53%) activity. Although FVIII activity had not been checked initially, it remained consistently low during follow-up. The FVIII inhibitor test was negative, and a cross-mixing test supported the diagnosis of congenital hemophilia A. Genetic testing was not performed due to cost and patient preference. After initiating FVIII and FXIII replacement therapy, cranioplasty was performed without further bleeding. The patient recovered with minimal neurological deficits and remains functionally independent. This case underscores the need to consider undiagnosed congenital hemophilia in elderly patients with recurrent ASDH or unexplained postoperative rebleeding. Early, targeted coagulation studies, including FVIII and FXIII assays, are critical for diagnosis. Our findings suggest that even mild FXIII deficiency may exacerbate bleeding in hemophilia A, highlighting the limitations of routine coagulation tests. Adequate perioperative replacement of FVIII and FXIII can support safe neurosurgical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.